Amniotic fluid clusterin in pregnancies complicated by the preterm prelabor rupture of membranes

References

• Waters TP, Mercer B. Preterm PROM: prediction, prevention, principles. Clin Obstet Gynecol 2011;54:307–12.
   PubMed Web of Science ®Google Scholar
• Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178–93.
   PubMed Web of Science ®Google Scholar
• Dutta EH, Behnia F, Boldogh I, et al. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol Hum Reprod 2016;22:143–57.
   PubMed Web of Science ®Google Scholar
• Murtha AP, Menon R. Regulation of fetal membrane inflammation: a critical step in reducing adverse pregnancy outcome. Am J Obstet Gynecol 2015;213:447–8.
   PubMed Web of Science ®Google Scholar
• Romero R, Friel LA, Velez Edwards DR, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 2010;203:361 e361–e330.
   Web of Science ®Google Scholar
• Lannon SM, Vanderhoeven JP, Eschenbach DA, et al. Synergy and interactions among biological pathways leading to preterm premature rupture of membranes. Reprod Sci 2014;21:1215–27.
   PubMed Web of Science ®Google Scholar
• Romero R, Miranda J, Chaemsaithong P, et al. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2015;28:1394–409.
   PubMed Web of Science ®Google Scholar
• Cobo T, Palacio M, Martinez-Terron M, et al. Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. Am J Obstet Gynecol 2011;205:126 e121–8.
   Web of Science ®Google Scholar
• Musilova I, Kutova R, Pliskova L, et al. Intraamniotic inflammation in women with preterm prelabor rupture of membranes. PLoS One 2015;10:e0133929.
   PubMed Web of Science ®Google Scholar
• Le Ray I, Mace G, Sediki M, et al. Changes in maternal blood inflammatory markers as a predictor of chorioamnionitis: a prospective multicenter study. Am J Reprod Immunol 2015;73:79–90.
   PubMed Web of Science ®Google Scholar
• Dorfeuille N, Morin V, Tetu A, et al. Vaginal fluid inflammatory biomarkers and the risk of adverse neonatal outcomes in women with PPROM. Am J Perinatol 2016;33:1003–7.
   PubMed Web of Science ®Google Scholar
• Buhimschi CS, Sfakianaki AK, Hamar BG, et al. A low vaginal “pool” amniotic fluid glucose measurement is a predictive but not a sensitive marker for infection in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2006;194:309–16.
   PubMed Web of Science ®Google Scholar
• Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839–51.
   PubMed Web of Science ®Google Scholar
• Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;169:805–16.
   PubMed Web of Science ®Google Scholar
• Romero R, Jimenez C, Lohda AK, et al. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990;163:968–74.
   PubMed Web of Science ®Google Scholar
• Tambor V, Kacerovsky M, Andrys C, et al. Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis. PLoS One 2012;7:e41164.
   PubMed Web of Science ®Google Scholar
• Fritz IB, Burdzy K, Setchell B, Blaschuk O. Ram rete testis fluid contains a protein (clusterin) which influences cell–cell interactions in vitro. Biol Reprod 1983;28:1173–88.
   PubMed Web of Science ®Google Scholar
• Choi NH, Mazda T, Tomita M. A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes. Mol Immunol 1989;26:835–40.
   PubMed Web of Science ®Google Scholar
• Choi NH, Nakano Y, Tobe T, et al. Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement. Int Immunol 1990;2:413–17.
   PubMed Web of Science ®Google Scholar
• Falgarone G, Chiocchia G. Chapter 8: Clusterin: a multifacet protein at the crossroad of inflammation and autoimmunity. Adv Cancer Res 2009;104:139–70.
   PubMed Web of Science ®Google Scholar
• Grima J, Zwain I, Lockshin RA, et al. Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. Endocrinology 1990;126:2989–97.
   PubMed Web of Science ®Google Scholar
• Jordan-Starck TC, Lund SD, Witte DP, et al. Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis. J Lipid Res 1994;35:194–210.
   PubMed Web of Science ®Google Scholar
• Oztas E, Ozler S, Ersoy AO, et al. Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia. J Perinat Med 2016;44:269–75.
   PubMed Web of Science ®Google Scholar
• Kolla V, Jeno P, Moes S, et al. Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia. J Biomed Biotechnol 2012;2012:305964.
   PubMedGoogle Scholar
• Blumenstein M, McCowan LM, Wu S, et al. Plasma clusterin increased prior to small for gestational age (SGA) associated with preeclampsia and decreased prior to SGA in normotensive pregnancies. Reprod Sci 2012;19:650–7.
   PubMed Web of Science ®Google Scholar
• Shin JK, Han KA, Kang MY, et al. Expression of clusterin in normal and preeclamptic placentas. J Obstet Gynaecol Res 2008;34:473–9.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Hamada H, Yamada N, et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics 2004;4:537–43.
   PubMed Web of Science ®Google Scholar
• Musilova I, Andrys C, Drahosova M, et al. Amniotic fluid calreticulin in pregnancies complicated by the preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2016;29:3921–9.
   PubMed Web of Science ®Google Scholar
• Musilova I, Andrys C, Drahosova M, et al. Amniotic fluid cathepsin-G in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2016. [Epub ahead of print]. doi: 10.1080/14767058.2016.1237499.
   Web of Science ®Google Scholar
• Kacerovsky M, Musilova I, Hornychova H, et al. Bedside assessment of amniotic fluid interleukin-6 in preterm prelabor rupture of membranes. Am J Obstet Gynecol 2014;211:385.e1–9.
   PubMed Web of Science ®Google Scholar
• Fouhy F, Deane J, Rea MC, et al. The effects of freezing on faecal microbiota as determined using MiSeq sequencing and culture-based investigations. PLoS One 2015;10:e0119355.
   PubMed Web of Science ®Google Scholar
• Greisen K, Loeffelholz M, Purohit A, Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 1994;32:335–51.
   PubMed Web of Science ®Google Scholar
• Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A rapid interleukin-6 bedside test for the identification of intra-amniotic inflammation in preterm labor with intact membranes. J Matern Fetal Neonatal Med 2016;29:349–59.
   PubMed Web of Science ®Google Scholar
• Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection. J Matern Fetal Neonatal Med 2016;29:360–7.
   PubMed Web of Science ®Google Scholar
• Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002;34:427–31.
   PubMed Web of Science ®Google Scholar
• Aronow BJ, Lund SD, Brown TL, et al. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA. 1993;90:725–9.
   PubMed Web of Science ®Google Scholar
• Hallstrom T, Uhde M, Singh B, et al. Pseudomonas aeruginosa uses dihydrolipoamide dehydrogenase (Lpd) to bind to the human terminal pathway regulators vitronectin and clusterin to inhibit terminal pathway complement attack. PLoS One 2015;10:e0137630.
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058–66.
   PubMed Web of Science ®Google Scholar
• Kirszbaum L, Sharpe JA, Murphy B, et al. Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems. EMBO J 1989;8:711–18.
   PubMed Web of Science ®Google Scholar
• Jenne DE, Lowin B, Peitsch MC, et al. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A–I in human plasma. J Biol Chem 1991;266:11030–6.
   PubMed Web of Science ®Google Scholar
• Singh B, Su YC, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol 2010;78:545–60.
   PubMed Web of Science ®Google Scholar
• Zipfel PF, Wurzner R, Skerka C. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 2007;44:3850–7.
   PubMed Web of Science ®Google Scholar
• Zipfel PF, Hallstrom T, Riesbeck K. Human complement control and complement evasion by pathogenic microbes-tipping the balance. Mol Immunol 2013;56:152–60.
   PubMed Web of Science ®Google Scholar